Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
1.
Auris Nasus Larynx ; 43(3): 247-53, 2016 Jun.
Article in English | MEDLINE | ID: mdl-26386497

ABSTRACT

OBJECTIVE: The aim of the study is to evaluate the usefulness of multislice computed tomography (MSCT) using multiplanar reconstruction (MPR) in obtaining preoperative information on the ossicular lesions of middle ear diseases by comparing the ossicular findings of MPR images with the operative findings. METHODS: Sixty-two ears and 10 ears with preoperative middle ear diseases underwent 4- and 64-detector row CT of the temporal bone in Kagawa University Hospital, respectively. MPR images of three ossicles were created at the planes parallel to the long axis of ossicles. RESULTS: The findings of the three ossicles in MPR images were compatible with their operative findings in approximately 91% of 72 ears with various middle ear diseases. There was no significant difference in the coincidence rate of both findings between 4- and 64-detector row CT scanners. The ears with no soft tissue shadows around the ossicles had the coincidence rate of 96-100% in each ossicular part, whereas the coincidence rate was lower in the ears with soft tissue shadows around the ossicles. CONCLUSION: MPR imagings of the ossicles provide accurate preoperative information on the ossicular lesions in middle ear diseases. The 4-detector CT is still a useful device for imaging of the ossicles.


Subject(s)
Cholesteatoma, Middle Ear/diagnostic imaging , Ear Ossicles/diagnostic imaging , Ear, Middle/diagnostic imaging , Otitis Media/diagnostic imaging , Adolescent , Adult , Aged , Child , Child, Preschool , Cholesteatoma, Middle Ear/surgery , Chronic Disease , Ear Ossicles/surgery , Ear, Middle/surgery , Female , Humans , Image Processing, Computer-Assisted , Imaging, Three-Dimensional , Male , Middle Aged , Multidetector Computed Tomography , Otitis Media/surgery , Preoperative Care , Young Adult
2.
J Maxillofac Oral Surg ; 14(3): 616-23, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26225053

ABSTRACT

INTRODUCTION: Nedaplatin (cis-diammine-glycolate platinum) is a new anticancer agent developed in Japan. It is especially designed to reduce adverse side effects of CDDP such as renal toxicity and neurotoxicity. AIM: We used nedaplatin as a superselective intra-arterial infusion chemotherapy for oral cancers and carried out a pharmacological study of the dose clearance of nedaplatin based on renal function as well as evaluating its efficacy, including hematological side effects. PATIENTS AND METHODS: Typical regimens of this chemotherapy consisted of 5-days straight of 24-h continuous intravenous infusion of 5-Fu with a single shot of nedaplatin via transfemoral artery on day 4. The dose of nedaplatin was calculated based on the 24-h creatine clearance. A total of 37 patients who had oral cancer and had received 68 courses (total) of chemotherapy were found to be eligible for this study. RESULTS: Total and free platinum concentrations in the plasma were measured at each of the time points, and the area under the curve (AUC, measured in units of µg h/ml) was calculated based on the platinum concentration with the following formula: CL (clearance of free platinum: l/h) = 0.042 × CCr (ml/min) + 5.84. The response rate was 70.1 % (in CR 51 %, in PR 19 %). Histological CR was seen in 28.6 % of surgical specimens. Moderate hematological side effects were seen. However, severe adverse events were not observed, including those associated with cannulation of the femoral artery. CONCLUSION: The dose-clearance formula that was established by our study can most likely be utilized to accurately predict the optimal administered dose of nedaplatin for arterial infusion chemotherapy.

3.
Auris Nasus Larynx ; 40(1): 36-40, 2013 Feb.
Article in English | MEDLINE | ID: mdl-22607998

ABSTRACT

OBJECTIVE: The aim of this study was to assess the value of multislice computed tomography (MSCT) using multiplanar reconstruction (MPR) to detect the small fenestral lesions in patients with otosclerosis. METHODS: MSCT with MPR imaging was used to evaluate 27 ears of 17 patients with otosclerosis (3 male and 14 females) ranging in age from 33 to 69 years with a mean of 49.8 year. MSCT imaging was performed using Aquilion®. Axial spiral scans with a 0.5-mm slice thickness were obtained. The acquired high-resolution data were transferred to a workstation (ALATO VIEW). MPR images were created in the planes parallel to the stapedial crus and then analyzed on the monitor screen by two radiologists (Y.T. and N.K.). RESULTS: MPR images showed abnormal findings in 26 of 27 ears with otosclerosis (96%), whereas axial images showed abnormal findings in only 15 of 27 ears (56%). The similar classification between both images was shown only in 9 of 27 ears (33%). In 16 ears (67%) axial images under-evaluated the lesions compared with MPR images. MPR images detected smaller foci than axial images. Air-bone gap at 0.5-4kHz tended to increase dependently on the extension of fenestral lesions evaluated by MPR images. CONCLUSION: MPR images detected fenestral lesions in otosclerosis more frequently and more precisely than axial images. The extent of fenestral lesions observed on MPR images tends to be related to the degree of conductive hearing loss.


Subject(s)
Cochlea/diagnostic imaging , Image Processing, Computer-Assisted/methods , Multidetector Computed Tomography , Otosclerosis/diagnostic imaging , Radiographic Image Enhancement/methods , Adult , Aged , Female , Hearing Loss, Conductive/etiology , Humans , Male , Middle Aged
5.
Auris Nasus Larynx ; 39(6): 567-71, 2012 Dec.
Article in English | MEDLINE | ID: mdl-22341927

ABSTRACT

OBJECTIVE: Previous studies, in which the vestibular aqueduct (VA) was determined using axial CT, have indicated that the VA sizes in patients with Ménière's disease were smaller than those in the subjects of the control group and that 25-35% of ears with Ménière's disease were "non-visible type." In this study, in addition to obtaining the axial size, we measured the VA size along the vertical plane by using vertical multiplanar reconstruction (MPR) images. METHODS: The VA size of both ears of patients with unilateral Ménière's disease (n=34) and of subjects of the control group (n=30) was measured by using the vertical MPR and the axial CT images. RESULTS: The VA size was measured along the axial and vertical planes in all subjects. The parameters measured on the axial image of the VA correlated with each other; however, the parameters on the vertical MPR image did not correlate with those on the axial image. Values of parameters in the affected and nonaffected ears with Ménière's disease tended to be smaller than those in the control ear. The external aperture areas of the VA fenestra of the affected and nonaffected ears of patients with Ménière's disease were significantly smaller than that for the control ears. CONCLUSION: Our findings suggest that the vertical parameters of the VA yield information that is independent of that provided by the axial parameters. In both ears of patients with unilateral Ménière's disease, the VA tended to be thinner than those in the control ear.


Subject(s)
Meniere Disease/diagnostic imaging , Vestibular Aqueduct/diagnostic imaging , Adult , Aged , Case-Control Studies , Endolymphatic Hydrops/diagnostic imaging , Endolymphatic Hydrops/etiology , Endolymphatic Sac/diagnostic imaging , Female , Humans , Image Processing, Computer-Assisted , Male , Meniere Disease/complications , Middle Aged , Tomography, X-Ray Computed
7.
Ann Nucl Med ; 20(2): 157-60, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16615426

ABSTRACT

Primary ovarian lymphoma as the initial manifestation is rare. A 27-year-old woman presented to our hospital with the symptoms of lower abdominal fullness and pollakisuria. CT scan and MRI revealed bilateral ovarian tumors, which showed heterogeneous masses. 18F-FDG PET revealed strong uptake by the abdominal masses, and the maximum standardized uptake value (SUVmax) was 12.5. Abnormal uptake was not shown by other regions. An exploratory laparotomy was performed. Histological findings revealed diffuse large B-cell lymphoma. The clinical stage was IV according to the Ann Arbor system. International prognostic index (IPI) was 3 (high-intermediate risk). Chemotherapy was administered consisting of three courses of an R-CHOP regimen, and 18F-FDG PET and CT scan revealed no signs of involvement 3 months after initiation of the chemotherapy. 18F-FDG PET was a useful method for staging and assessment of the therapeutic response in primary ovarian lymphoma.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Fluorodeoxyglucose F18 , Lymphoma, Non-Hodgkin/diagnostic imaging , Lymphoma, Non-Hodgkin/drug therapy , Ovarian Neoplasms/diagnostic imaging , Ovarian Neoplasms/drug therapy , Positron-Emission Tomography/methods , Adult , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Doxorubicin/analogs & derivatives , Female , Humans , Lymphoma, Non-Hodgkin/pathology , Neoplasm Staging/methods , Ovarian Neoplasms/pathology , Prednisone/administration & dosage , Prognosis , Radiopharmaceuticals , Treatment Outcome , Vincristine/administration & dosage
8.
Radiat Med ; 23(5): 309-16, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16342901

ABSTRACT

Brain damage after head injury can be classified by its time course. Primary damage that includes acute subdural hematoma (SDH), acute epidural hematoma (EDH), and intraaxial lesions that include contusions, diffuse axonal injury (DAI), and intracranial hemorrhage (ICH), occurs at the moment of impact and is thought to be irreversible. Secondary damage that includes herniations, diffuse cerebral swelling, and secondary infarction and hemorrhage, evolves hours or days after injury as a consequence of systemic or intracranial complications. The duration and severity of secondary damage influence outcome. Head injury management is focused on preventing, detecting, and correcting such secondary damage. CT has been widely used for the neuromonitoring of head trauma. CT is the gold standard for the detection of intracranial abnormalities and is a safe method for survey. While MRI is more sensitive and accurate in diagnosing cerebral pathology, CT is considered the most critical imaging technique for the management of closed head-injured patients in the acute stage. In this article, we review the imaging findings and literature of various lesions of closed head injury in the acute stage.


Subject(s)
Brain Injuries/diagnosis , Brain/diagnostic imaging , Head Injuries, Closed/diagnosis , Tomography, X-Ray Computed/methods , Acute Disease , Humans
9.
Int J Clin Oncol ; 10(4): 285-8, 2005 Aug.
Article in English | MEDLINE | ID: mdl-16136377

ABSTRACT

Occult breast cancer presenting with axillary lymph node metastases is uncommon, and inflammatory breast cancer (IBC), as a subtype, is quite rare. Here we describe a case of IBC, which arose as an unknown primary carcinoma; the patient presented with axillary lymph node metastasis, and was successfully treated with trastuzumab and vinorelbine. Specifically, a 55-year-old woman presented with right axillary lymphadenopathy. Although she underwent various examinations, the primary site of the disease was not revealed. Axillary lymph node dissection was performed, and the lesion was diagnosed as a poorly differentiated adenocarcinoma. The patient chose to be treated by alternative medicine. About 6 months later, she was referred to our hospital, due to marked bilateral neck and axillary lymph node swelling. She presented with diffuse right breast enlargement, redness, and peau d'orange. Computed tomography (CT) of the breast showed skin thickening and swelling of the right breast.F-18 Fluorodeoxyglucose positron emission tomography (FDG-PET) showed FDG uptake in the right breast. The patient was clinically diagnosed with IBC. Because overexpression of the human epidermal growth factor receptor 2 (HER2) was found in the specimen from her right axillary lymph node, she was treated with trastuzumab and vinorelbine. Two months after the start of chemotherapy, CT revealed a complete response in the lymph nodes, and the skin thickening and parenchymal edema of the right breast had improved. FDG-PET was also performed at this time, and revealed no FDG uptake in either the right breast or the lymph nodes.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/diagnosis , Breast Neoplasms/drug therapy , Neoplasms, Unknown Primary/diagnosis , Adenocarcinoma/diagnosis , Adenocarcinoma/drug therapy , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal, Humanized , Axilla , Breast Neoplasms/diagnostic imaging , Female , Fluorodeoxyglucose F18 , Humans , Lymphatic Diseases , Lymphatic Metastasis/pathology , Middle Aged , Neoplasm Staging , Neoplasms, Unknown Primary/drug therapy , Radiopharmaceuticals , Receptor, ErbB-2/metabolism , Tomography, Emission-Computed , Trastuzumab , Treatment Outcome , Vinblastine/administration & dosage , Vinblastine/analogs & derivatives , Vinorelbine
10.
Clin Imaging ; 29(5): 342-4, 2005.
Article in English | MEDLINE | ID: mdl-16153541

ABSTRACT

Magnetic resonance (MR) cholangiography has been used wildly as preoperative examination before laparoscopic cholecystectomy (LSC). However, cases that suggested the stenotic lesion of extrahepatic bile duct are not so rare in MR cholangiography. When stenosis is found, further examination is needed to avoid the possibility of bile duct cancer. We reported a case in which the stenotic lesion was diagnosed compression of the common hepatic duct by the right hepatic artery by multislice CT (MCT) cholangiography.


Subject(s)
Bile Duct Diseases/diagnosis , Cholangiopancreatography, Magnetic Resonance , Hepatic Artery/pathology , Hepatic Duct, Common/pathology , Bile Duct Diseases/surgery , Cholecystectomy, Laparoscopic , Hepatic Artery/surgery , Hepatic Duct, Common/surgery , Humans , Male , Middle Aged , Preoperative Care
11.
Am J Surg ; 189(1): 53-5, 2005 Jan.
Article in English | MEDLINE | ID: mdl-15701492

ABSTRACT

BACKGROUND: This study aimed to determine the frequency of anatomic variations of bile ducts (aberrant bile ducts) using multislice helical computed tomography (MCT) cholangiography. METHODS: MCT scanning was performed after slow infusion of 100 mL meglumine iotroxate. Overlapping axial images, taken at 0.5-mm intervals, were reconstructed to create a multiplanar reconstruction with volume rendering. We analyzed anatomical variations of the biliary tree by MCT cholangiography. RESULTS: In a total of 113 patients, MCT cholangiography provided clear images of aberrant bile ducts in 18 patients. Major type (draining a particular segment of the liver) was found in 9 cases (8%) and minor type (draining a particular subsegment of the liver) in 9 cases (8%). CONCLUSIONS: Preoperative MCT cholangiography provides important information about the precise biliary anatomy and can reveal unexpected aberrant bile ducts prior to biliary surgery, especially laparoscopic cholecystectomy.


Subject(s)
Bile Ducts, Extrahepatic/abnormalities , Bile Ducts, Extrahepatic/diagnostic imaging , Biliary Tract Diseases/diagnostic imaging , Biliary Tract Diseases/surgery , Cholangiography/methods , Tomography, Spiral Computed/methods , Biliary Tract Diseases/pathology , Female , Hepatic Duct, Common/abnormalities , Hepatic Duct, Common/diagnostic imaging , Hepatic Duct, Common/surgery , Humans , Male , Middle Aged
12.
Nucl Med Commun ; 26(3): 239-44, 2005 Mar.
Article in English | MEDLINE | ID: mdl-15722904

ABSTRACT

AIM: The presence of simultaneous primary tumours in other regions affects the prognosis and management decisions of head and neck cancer patients. Therefore, early detection of these tumours is necessary. Recent improvements in positron emission tomography (PET) have made it possible to examine the patient's whole body. The present study was undertaken to evaluate the clinical contribution of whole-body PET using fluorodeoxyglucose (FDG) for head and neck cancer patients. METHODS: Fifty-three consecutive patients with previously untreated head and neck cancer were examined. Whole-body FDG PET imaging was performed at 1 h after injection of (18)F-FDG. A 3-D acquisition was undertaken and iterative reconstruction was performed. The final diagnosis of simultaneous primary tumour was established by histological findings or clinical follow-up. RESULTS: Of 53 patients, six (11%) had evidence of simultaneous primary tumour. In five of these six patients, simultaneous primary tumours (two gastric cancer; one colon cancer; one pancreatic cancer; one thyroid cancer) were found by FDG PET. One more patient was found to have prostate cancer on the basis of blood test but this was not detected by FDG PET. In none of the remaining 47 patients, were additional simultaneous primary tumours found by FDG PET or any of the other routine examinations or during follow-up. CONCLUSIONS: The results of this study show a high rate of simultaneous primary tumour in patients with primary head and neck cancer. FDG PET appears to be a promising imaging modality for the detection of simultaneous tumours in head and neck cancer patients.


Subject(s)
Fluorodeoxyglucose F18 , Head and Neck Neoplasms/diagnostic imaging , Neoplasms, Multiple Primary/diagnostic imaging , Positron-Emission Tomography/methods , Whole-Body Counting/methods , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Prognosis , Radiopharmaceuticals , Reproducibility of Results , Sensitivity and Specificity
13.
Radiat Med ; 23(6): 435-8, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16389987

ABSTRACT

We report a case of metastatic pulmonary calcification that appeared on high-resolution CT (HRCT) as multiple, lobular, ground-glass opacities sparing the perilobular area. Diffuse metastatic calcification such as that in our case was considered to be a result of postoperative transient acute renal failure. Decreasing alveolar air spaces due to both alveolar septal fibrosis and calcification caused the diffuse ground-glass opacities in the present case.


Subject(s)
Acute Kidney Injury/complications , Acute Kidney Injury/diagnostic imaging , Calcinosis/diagnostic imaging , Calcinosis/etiology , Lung Diseases/diagnostic imaging , Lung Diseases/etiology , Chest Pain/diagnosis , Chest Pain/etiology , Dyspnea/diagnosis , Dyspnea/etiology , Humans , Male , Middle Aged , Radiography
14.
Ann Nucl Med ; 19(8): 725-8, 2005 Dec.
Article in English | MEDLINE | ID: mdl-16445000

ABSTRACT

Pyothorax-associated lymphoma (PAL) is a non-Hodgkin's lymphoma developing in the pleural cavity after a long-standing history of chronic pyothorax (CP). F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) imaging is a useful modality for determination of disease extent of various malignant tumors, including malignant lymphoma, but there have been no reports describing the usefulness of FDG-PET imaging in PAL. Here we report a case of PAL that relapsed after chemotherapy and was successfully treated by radiotherapy. FDG-PET imaging revealed that the tumor was localized to a soft-tissue attenuation mass behind the CP cavity in the right thorax, but did not infiltrate the CP cavity. A total dose of 40 Gy was administered to the area that included the PET-positive lesion, instead of including the entire CP cavity in the radiation field. Although computed tomography (CT) showed a residual mass, no FDG uptake was indicated by FDG-PET imaging performed just after the end of radiotherapy, and additional irradiation was not performed. No sign of relapse was found by FDG-PET imaging 3 months later. FDG-PET imaging was useful for both the planning of radiotherapy and assessing the treatment response of PAL.


Subject(s)
Empyema, Pleural/diagnostic imaging , Fluorodeoxyglucose F18 , Lymphoma, Non-Hodgkin/diagnostic imaging , Lymphoma, Non-Hodgkin/radiotherapy , Pleural Neoplasms/diagnostic imaging , Pleural Neoplasms/radiotherapy , Radiotherapy Planning, Computer-Assisted/methods , Aged , Empyema, Pleural/complications , Humans , Lymphoma, Non-Hodgkin/etiology , Pleural Neoplasms/etiology , Positron-Emission Tomography/methods , Prognosis , Radiopharmaceuticals , Radiotherapy, Computer-Assisted/methods , Treatment Outcome
15.
Ann Nucl Med ; 18(6): 527-32, 2004 Sep.
Article in English | MEDLINE | ID: mdl-15515754

ABSTRACT

OBJECTIVE: Cartilage invasion in laryngohypopharyngeal cancer has a significant impact on the choice of treatment modality and outcome of the disease. We examined invasion of cartilage in laryngohypopharyngeal cancer by simultaneous bone and tumor dual-isotope SPECT using 99mTc-hydroxymethylene diphosphonate and 201Tl-chloride. METHODS: Early and delayed simultaneous bone and tumor dual-isotope SPECT were performed on 19 patients with laryngohypopharyngeal cancer. Dual-isotope SPECT images were superimposed to project tumor location from tumor SPECT onto the osseous structures shown by bone SPECT. The presence or absence of cartilage invasion was evaluated histopathologically or by radiological studies such as CT and/or MRI. RESULTS: Histopathological or radiological examination of the cartilage revealed invasion in 5 patients and no invasion in 14 patients. The results of both early and delayed dual-isotope SPECT were exactly the same. Using dual-isotope SPECT, the sensitivity, specificity, and accuracy in detecting cartilage invasion by laryngohypopharyngeal cancer were: 80% (4/5), 92.9% (13/14), and 89.5% (17/19), respectively. CONCLUSIONS: Results of the present study suggest that superimposed early bone and tumor dual-isotope SPECT images may be sufficient for the diagnostic evaluation of cartilage invasion by laryngohypopharyngeal cancer. Superimposed dual-isotope SPECT imaging is a useful technique in the evaluation of cartilage invasion in laryngohypopharyngeal cancer.


Subject(s)
Cartilage/diagnostic imaging , Laryngeal Neoplasms/diagnostic imaging , Pharyngeal Neoplasms/diagnostic imaging , Risk Assessment/methods , Subtraction Technique , Technetium Tc 99m Medronate/analogs & derivatives , Thallium , Tomography, Emission-Computed, Single-Photon/methods , Aged , Female , Humans , Image Enhancement/methods , Laryngeal Cartilages/diagnostic imaging , Laryngeal Neoplasms/pathology , Male , Middle Aged , Neoplasm Invasiveness , Pharyngeal Neoplasms/pathology , Radiopharmaceuticals , Reproducibility of Results , Risk Factors , Sensitivity and Specificity
16.
Ann Nucl Med ; 18(3): 235-41, 2004 May.
Article in English | MEDLINE | ID: mdl-15233285

ABSTRACT

OBJECTIVE: The purpose of this study was to evaluate the usefulness of 201Tl scintigraphy in comparison with three-phase bone scintigraphy in the differentiation of residual/recurrent tumors from post-therapeutic changes, in patients previously treated for bone and soft-tissue tumors. METHODS: Thirty-five 201Tl and three-phase bone scintigraphy scans were obtained for 30 patients with a history of bone or soft-tissue tumor who had undergone chemotherapy, radiation therapy, tumor resection, or a combination of these treatments. The planar 201Tl images were acquired 10 mins (early) and 2 hrs (delayed) after the intravenous injection of 111 MBq 201Tl-chloride. Three-phase bone scintigraphy was performed using 740 MBq 99mTc-HMDP at the same lesion site as for 201Tl imaging. The blood flow images were obtained every 10 sec for 2 mins and were immediately followed by the blood pool image after 5 mins. Three to 4 hrs later, bone images were obtained. 201Tl and three-phase bone scintigraphies were correlated with the histopathologic findings and/or clinical follow-up of more than 3 months. RESULTS: Of the 35 cases, 15 were free of disease and 20 had residual or recurrent tumors. Of the 20 residual or recurrent cases, all had true-positive 201Tl early and delayed scans, while bone scintigraphy was true-positive on the blood flow, blood pool and bone images in 16, 18 and 12 cases, respectively. 201Tl early and delayed images and 99mTc-HMDP blood flow and blood pool images were false-positive in one patient. The histology of this false-positive case showed the presence of lymph proliferative tissue. CONCLUSIONS: Although 201Tl uptake after treatment does not always indicate recurrence, 201Tl scintigraphy may still be more useful than three-phase bone scintigraphy in the follow-up of patients with bone and soft-tissue tumors following therapy.


Subject(s)
Bone Neoplasms/diagnostic imaging , Bone Neoplasms/therapy , Neoplasm Recurrence, Local/diagnostic imaging , Soft Tissue Neoplasms/diagnostic imaging , Soft Tissue Neoplasms/therapy , Technetium Tc 99m Medronate/analogs & derivatives , Thallium , Adolescent , Adult , Aged , Aged, 80 and over , Diagnosis, Differential , Female , Humans , Male , Middle Aged , Neoplasm Recurrence, Local/prevention & control , Prognosis , Radionuclide Imaging , Radiopharmaceuticals , Reproducibility of Results , Sensitivity and Specificity , Treatment Outcome
17.
Radiat Med ; 22(2): 126-30, 2004.
Article in English | MEDLINE | ID: mdl-15176610

ABSTRACT

PURPOSE: The present study assessed the usefulness of CT for diagnosis of pulmonary emphysema (PE) using teleradiology. METHODS: We reviewed 95 cases (56 men and 39 women, ranging in age from 18 to 89 years) who had undergone CT examination between June 2002 and January 2003. CT images were transmitted via ISDN by DICOM to our hospital, and displayed in 4-image and 1-image format for reading on an image viewer. RESULTS: In 72 of the total 95 cases, both 1-image and 4-image displays were normal, and no PE was detected. Of the remaining 23 patients, PE was found in 22 on 4-image display and in all 23 on 1-image display. The same grade and subtype were observed on 4-image and 1-image displays in 19 cases. On the other hand, difference in diagnosis between the two types of display was obtained in four cases, in which mild low attenuation areas (LAAs) such as grade 1 or grade 2 centrilobular emphysema were found on the 1-image display but not seen on the 4-image display. CONCLUSIONS: The diagnosis of PE can be made by CT examination using teleradiology even in cases of mild lesions, when, for example, LAAs were found on the 1-image display but not seen on the other one. Therefore, teleradiology enables rapid diagnosis even in medical institutions where no expert chest radiologist is present.


Subject(s)
Pulmonary Emphysema/diagnostic imaging , Teleradiology , Tomography, X-Ray Computed , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged
18.
Gan To Kagaku Ryoho ; 31(5): 713-6, 2004 May.
Article in Japanese | MEDLINE | ID: mdl-15170978

ABSTRACT

Area under the curve (AUC) is a very important parameter for determination of optimal dosage of antineoplastic agents in order to avoid side effects and achieve high effectiveness. Also, even if a certain dosage is administered, measured AUC is different in each individual. Therefore, it is important to determine the formula of the dosage of antineoplastic agents. We treated oral cancer using an intra-arterial infusion chemotherapy with nedaplatin (CDGP). Eighteen patients were treated with CDGP at the Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa Medical University, from October 1998 to June 2002. The correlation among expected AUC, dosage, CDGP clearance and 24 hr creatinine clearance in all chemotherapy was monitored and examined. The obtained formula in the dosage of intra-arterial infusion chemotherapy with Nedaplatin was as follows. dosage = AUC x (0.027 x CCr + 7.17).


Subject(s)
Antineoplastic Agents/administration & dosage , Carcinoma, Squamous Cell/drug therapy , Mouth Neoplasms/drug therapy , Organoplatinum Compounds/administration & dosage , Aged , Aged, 80 and over , Area Under Curve , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Humans , Infusions, Intra-Arterial , Male , Middle Aged
19.
Gan To Kagaku Ryoho ; 31(1): 41-4, 2004 Jan.
Article in Japanese | MEDLINE | ID: mdl-14750319

ABSTRACT

We treated oral cancer using a targeting intra-arterial infusion chemotherapy with CDGP (nedaplatin); dosages were determined by the original formula. We compared the expected AUC (area under the curve) with the actual AUC in primary oral cancer cases to assess the optimal dosage of CDGP for intra-arterial chemotherapy and to study relevance of AUC, effectiveness of independent chemotherapy and side effects. Eleven cases were treated at the Department of Oral and Maxillofacial Surgery, Faculty of Medicine, Kagawa Medical University, from October 1998 to June 2002. The results are as follows. 1) A correlation was seen between the AUC and degree of thrombocytopenia. 2) AUC may reveal renal function, especially for GFR. 3) The response rate of the targeted intra-arterial infusion chemotherapy with CDGP was remarkably high and serious side effects were not observed. It appears that the set-up of the optimum dose should be decided based on the actual AUC. 4) There was about a 4/3 difference between the value of the expected AUC and the actual AUC. The equation for dosages based on the actual AUC needs to be studied further.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Area Under Curve , Carcinoma, Squamous Cell/drug therapy , Mouth Neoplasms/drug therapy , Organoplatinum Compounds/administration & dosage , Aged , Aged, 80 and over , Carcinoma, Squamous Cell/physiopathology , Dose-Response Relationship, Drug , Drug Administration Schedule , Female , Fluorouracil/administration & dosage , Glomerular Filtration Rate , Humans , Infusions, Intra-Arterial , Male , Middle Aged , Mouth Neoplasms/physiopathology , Organoplatinum Compounds/adverse effects , Organoplatinum Compounds/blood , Thrombocytopenia/chemically induced
20.
Ann Nucl Med ; 17(8): 657-62, 2003 Dec.
Article in English | MEDLINE | ID: mdl-14971607

ABSTRACT

OBJECTIVE: 67Ga scintigraphy has a well-documented role in nodal lymphoma for both disease staging and assessment of treatment response. The objective of the present study was to examine the role of 67Ga scintigraphy in diagnosis and assessment of treatment response, in patients with extranodal malignant lymphoma. METHODS: Seventy-one patients with extranodal malignant lymphoma were studied. Whole body scans in all and SPECT scans in some selected patients were performed 72 hours after injection of 67Ga-citrate. The influence of tumor site, histological classification and tumor size on 67Ga scintigraphy sensitivity was analyzed. Twenty-one of the seventy-one patients also had a second 67Ga scintigraphy to assess response to treatment. RESULTS: The overall 67Ga scintigraphy sensitivity was 83.1% (59/71). The sensitivity was low in patients whose extranodal lymphoma occurred in skin (0/3) and urinary bladder (0/1), as compared to other tumor sites. According to the histological classification of the lesion, the sensitivity was lower in low-grade than in intermediate and high-grade lymphoma. According to the tumor size, the sensitivity was low in lesions less than 2 cm in diameter than those more than 2 cm in diameter. The results changed from positive to negative accumulation in 20 (95.2%) of the 21 patients who had 67Ga scintigraphy to assess the response to treatment. These 20 patients showed a good clinical course. CONCLUSIONS: Although 67Ga scintigraphy did not show positive accumulation in patients with skin and urinary bladder lymphoma, it was helpful to confirm the diagnosis and to evaluate the therapeutic effect in most patients with extranodal malignant lymphoma.


Subject(s)
Citrates , Gallium , Lymphoma/diagnostic imaging , Neoplasms/diagnostic imaging , Adult , Aged , Aged, 80 and over , Female , Humans , Lymphatic Metastasis , Lymphoma/pathology , Male , Middle Aged , Neoplasms/pathology , Radiopharmaceuticals , Reproducibility of Results , Sensitivity and Specificity , Tomography, Emission-Computed, Single-Photon/methods , Whole-Body Counting/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...